Related Experiment Video
Updated: Aug 10, 2025

Whole Genome Sequencing of Candida glabrata for Detection of Markers of Antifungal Drug Resistance
Published on: December 28, 2017
Candida auris as an Emergent Public Health Problem: A Current Update on European Outbreaks and Cases
Nicholas Geremia1, Pierluigi Brugnaro2, Maria Solinas3
1Unit of Infectious Diseases, Department of Clinical Medicine, Ospedale "dell'Angelo", 30174 Venice, Italy.
Abstract:
Candida auris is considered to be an emerging fungal pathogen and is related to high mortality rates, persistent candidemia, inconsistencies in susceptibility testing results and misidentification by available commercial identification systems. Multidrug-resistant (MDR) and pandrug-resistant (PDR) strains are increasingly detected. In Europe, hospital outbreaks caused by C. auris have been reported in the United Kingdom (UK), Italy and Spain; however, several cases have been sporadically detected in all European countries. C. auris is difficult to control despite enhanced control measures due to its ability to survive for a long time in environments and colonize patients for prolonged periods. An adequate laboratory diagnostic capacity and national surveillance are fundamental to rapidly detect new C. auris cases and to apply the correct measures to circumscribe them and prevent their spread. Our narrative review aims to highlight the primary C. auris outbreaks and case reports that have occurred in Europe.
Insights
Candida auris, an emerging fungal pathogen, causes difficult-to-control outbreaks with high mortality. This review highlights European cases and emphasizes the need for laboratory diagnostics and surveillance to manage this multidrug-resistant threat.
Area of Science:
- Medical Mycology
- Infectious Diseases
- Epidemiology
Background:
- Candida auris is an emerging fungal pathogen associated with high mortality rates.
- It exhibits multidrug-resistance (MDR) and pandrug-resistance (PDR), complicating treatment.
- C. auris poses significant challenges due to its environmental persistence and patient colonization.
Purpose of the Study:
- To review primary Candida auris outbreaks and case reports in Europe.
- To underscore the importance of laboratory diagnostics and surveillance for C. auris control.
Main Methods:
- Narrative review of published literature on Candida auris outbreaks and cases in Europe.
- Analysis of reported hospital outbreaks and sporadic cases across European countries.
Main Results:
- Significant Candida auris outbreaks have occurred in the UK, Italy, and Spain.
- Sporadic cases have been reported throughout Europe, indicating widespread presence.
- Challenges in susceptibility testing and identification by commercial systems are noted.
Conclusions:
- Effective control of Candida auris requires enhanced laboratory diagnostic capacity.
- Robust national surveillance systems are crucial for rapid detection and containment.
- Addressing C. auris necessitates a coordinated European approach to manage outbreaks.
Related Concept Videos
Steps in Outbreak Investigation
Healthcare Associated Infections II: Preventive Measures
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
Healthcare Associated Infections I: Iatrogenic, Exogenic and Endogenic
HAIs significantly increase the cost of health care. Extended stays in healthcare institutions, increased disability, increased costs of medications, including specialized antibiotics, and prolonged recovery times add to the patient's expenses and the healthcare institution and funding bodies.
Fungal Phylum Ascomycota
Infection
The chain begins with pathogens: bacteria, viruses, fungi, prions, or parasites such as protozoa helminths. These can be present on the skin as transient or resident flora, or they can be acquired from the environment. Identifying and treating the type of infection and...
Fungal Phylum Microsporidia

